94 related articles for article (PubMed ID: 3125927)
1. Centrally acting drugs.
Bateman DN; Chaplin S
Br Med J (Clin Res Ed); 1988 Feb; 296(6619):417-9. PubMed ID: 3125927
[No Abstract] [Full Text] [Related]
2. [The interaction of drugs acting predominantly on the CNS].
Zelikson IuI; Davydova ON
Med Sestra; 1988 Nov; 47(11):45-52. PubMed ID: 3221755
[No Abstract] [Full Text] [Related]
3. [On new mechanisms of action of centrally active drugs].
Castrén E; Panula P
Duodecim; 2003; 119(15):1487-95. PubMed ID: 14502828
[No Abstract] [Full Text] [Related]
4. Drugs and mood changes.
Kitchen I
Nursing (Lond); 1984 Apr; 2(24):719-21. PubMed ID: 6563458
[No Abstract] [Full Text] [Related]
5. [New drugs in neurology].
Mattle HP
Praxis (Bern 1994); 1999 Apr; 88(18):827-34. PubMed ID: 10409881
[TBL] [Abstract][Full Text] [Related]
6. Clinical applications of centrally acting agents in male sexual dysfunction.
Hellstrom WJ
Int J Impot Res; 2008 Jul; 20 Suppl 1():S17-23. PubMed ID: 18552830
[TBL] [Abstract][Full Text] [Related]
7. Drugs to treat Alzheimer's disease.
J Psychosoc Nurs Ment Health Serv; 2009 Apr; 47(4):13-4. PubMed ID: 19437925
[No Abstract] [Full Text] [Related]
8. Central nervous system agents in the treatment of erectile dysfunction.
Kendirci M; Walls MM; Hellstrom WJ
Urol Clin North Am; 2005 Nov; 32(4):487-501, vii. PubMed ID: 16291040
[TBL] [Abstract][Full Text] [Related]
9. Positive Beers criteria: limitations.
Linnebur SA; Vande Griend JP; Dugan JP; Page RL
Consult Pharm; 2009 Nov; 24(11):792; author reply 792, 794. PubMed ID: 20092217
[No Abstract] [Full Text] [Related]
10. Outside the box.
Newnes C
Ment Health Today; 2006 Nov; ():21. PubMed ID: 17133682
[No Abstract] [Full Text] [Related]
11. Optimism in the treatment of Alzheimer's disease.
Carrier L
J Psychiatry Neurosci; 1999 Nov; 24(5):398-401. PubMed ID: 10586531
[No Abstract] [Full Text] [Related]
12. Drug development for CNS disorders: strategies for balancing risk and reducing attrition.
Pangalos MN; Schechter LE; Hurko O
Nat Rev Drug Discov; 2007 Jul; 6(7):521-32. PubMed ID: 17599084
[TBL] [Abstract][Full Text] [Related]
13. [Symptomatic therapy of multiple sclerosis].
Henze T
Nervenarzt; 2004 Aug; 75 Suppl 1():2-39. PubMed ID: 15480526
[No Abstract] [Full Text] [Related]
14. The use of central nervous system drugs and analgesics among very old people with and without dementia.
Lövheim H; Karlsson S; Gustafson Y
Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):912-8. PubMed ID: 18398935
[TBL] [Abstract][Full Text] [Related]
15. Prescribing CNS drugs for elderly patients.
Ghose K
Drugs Aging; 1994 Apr; 4(4):275-84. PubMed ID: 8019051
[No Abstract] [Full Text] [Related]
16. The use of ANAM to assess the side-effect profiles and efficacy of medication.
Wilken JA; Sullivan CL; Lewandowski A; Kane RL
Arch Clin Neuropsychol; 2007 Feb; 22 Suppl 1():S127-33. PubMed ID: 17116387
[TBL] [Abstract][Full Text] [Related]
17. New drugs of the year, Part 2.
Rodman MJ
RN; 1983 May; 46(5):69, 72, 74 passim. PubMed ID: 6552025
[No Abstract] [Full Text] [Related]
18. Journal of Child and Adolescent Psychopharmacology. From the Editor-in-Chief's desk.
Koplewicz HS
J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):431. PubMed ID: 24041407
[No Abstract] [Full Text] [Related]
19. [Drugs and traffic].
Mattila MJ
Duodecim; 1984; 100(19):1234-43. PubMed ID: 6510285
[No Abstract] [Full Text] [Related]
20. [Interaction between neurological and psychological control mechanisms].
Robberstad M
Tidsskr Nor Laegeforen; 1983 Feb; 103(4):295-7. PubMed ID: 6857611
[No Abstract] [Full Text] [Related]
[Next] [New Search]
